Investigated event: Influence on cell proliferation

Name Value
Compound Atiprimod
Investigated event Influence on cell proliferation
Experiment type MTT Assay
Concentration 0.20 µM
Cell line FDCP-EpoR JAK2V617F
Organism Mus musculus
Animal model
STAT protein
Other
Reference
Preclinical characterization of tyrosine kinase inhibitor-based targeted therapies for neuroendocrine thyroid cancer. Oncotarget Karine Pozo, Stefan Zahler, Keisuke Ishimatsu, Angela M Carter, Rahul Telange, Chunfeng Tan, Shuaijun Wang, Roswitha Pfragner, Junya Fujimoto, Elizabeth Gardner Grubbs, Masaya Takahashi, Sarah C Oltmann, James A Bibb, 9, 102, 2018-12-28, 2018-12-28, 10.18632/oncotarget.26480 DOI: 10.18632/oncotarget.26480 PUBMED: 30701022 PMCID: PMC6340867